223 related articles for article (PubMed ID: 32766130)
41. Adjuvant Chemotherapy Seemed Not to Have Survival Benefit in Rectal Cancer Patients with ypTis-2N0 After Preoperative Radiotherapy and Surgery from a Population-Based Propensity Score Analysis.
Hu X; Li YQ; Li QG; Ma YL; Peng JJ; Cai SJ
Oncologist; 2019 Jun; 24(6):803-811. PubMed ID: 29674444
[TBL] [Abstract][Full Text] [Related]
42. Features of T1 pancreatic cancer and validation of the eighth edition AJCC staging system definition using a Korean-Japanese joint cohort and the SEER database.
Kwon W; Heo JS; Han IW; Kang CM; Hwang HK; Kim SC; Park SJ; Yoon YS; Kim YH; Lim CS; Lee SY; Park T; Takami H; Watanabe N; Shimizu Y; Okuno M; Yamaue H; Kawai M; Seiko H; Nagakawa Y; Osakabe H; Sugiura T; Toyama H; Ohtsuka M; Unno M; Endo I; Kitago M; Jang JY
J Hepatobiliary Pancreat Sci; 2023 Sep; 30(9):1129-1140. PubMed ID: 36734142
[TBL] [Abstract][Full Text] [Related]
43. Long-term survival in patients with pancreatic ductal adenocarcinoma.
Stark AP; Sacks GD; Rochefort MM; Donahue TR; Reber HA; Tomlinson JS; Dawson DW; Eibl G; Hines OJ
Surgery; 2016 Jun; 159(6):1520-1527. PubMed ID: 26847803
[TBL] [Abstract][Full Text] [Related]
44. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis.
Ecker BL; McMillan MT; Datta J; Mamtani R; Giantonio BJ; Dempsey DT; Fraker DL; Drebin JA; Karakousis GC; Roses RE
Cancer; 2016 Mar; 122(5):693-701. PubMed ID: 26717303
[TBL] [Abstract][Full Text] [Related]
45. Proposed Modification of the 8th Edition of the AJCC Staging System for Pancreatic Ductal Adenocarcinoma.
Shi S; Hua J; Liang C; Meng Q; Liang D; Xu J; Ni Q; Yu X
Ann Surg; 2019 May; 269(5):944-950. PubMed ID: 29334560
[TBL] [Abstract][Full Text] [Related]
46. Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with previous malignancies: A propensity score-matched analysis.
Zhou K; Zhao Y; Liang L; Cao J; Lin H; Peng Z; Mei J
Front Oncol; 2022; 12():938195. PubMed ID: 36119504
[TBL] [Abstract][Full Text] [Related]
47. Equipping the American Joint Committee on Cancer Staging for Resectable Pancreatic Ductal Adenocarcinoma with Tumor Grade: A Novel Staging System.
Ren H; Wu CR; Qiu GT; Zhang LP; Aimaiti S; Wang CF
J Oncol; 2020; 2020():9093729. PubMed ID: 33014058
[TBL] [Abstract][Full Text] [Related]
48. Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis.
Wang Y; Zhang J; Guo S; Dong Z; Meng X; Zheng G; Yang D; Zheng Z; Zhao Y
Clin Transl Oncol; 2019 Nov; 21(11):1499-1509. PubMed ID: 30903518
[TBL] [Abstract][Full Text] [Related]
49. External radiation is associated with limited improvement in overall survival in resected margin-negative stage IIB pancreatic adenocarcinoma.
Kantor O; Talamonti MS; Lutfi W; Wang CH; Winchester DJ; Marsh R; Prinz RA; Baker MS
Surgery; 2016 Dec; 160(6):1466-1476. PubMed ID: 27614417
[TBL] [Abstract][Full Text] [Related]
50. Distinct Survival Outcomes in Subgroups of Stage III Pancreatic Cancer Patients: Taiwan Cancer Registry and Surveillance, Epidemiology and End Results registry.
Lu TP; Wu CH; Chang CC; Chan HC; Chattopadhyay A; Lee WC; Chiang CJ; Lee HY; Tien YW
Ann Surg Oncol; 2022 Mar; 29(3):1608-1615. PubMed ID: 34775547
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant therapy for pancreatic body or tail adenocarcinoma: a study of the National Cancer Database.
Seaton M; Hanna A; Boutros C; Hanna N
Ther Adv Med Oncol; 2019; 11():1758835919842438. PubMed ID: 31105777
[TBL] [Abstract][Full Text] [Related]
52. Recent Trends in the Incidence and Survival of Stage 1A Pancreatic Cancer: A Surveillance, Epidemiology, and End Results Analysis.
Blackford AL; Canto MI; Klein AP; Hruban RH; Goggins M
J Natl Cancer Inst; 2020 Nov; 112(11):1162-1169. PubMed ID: 31958122
[TBL] [Abstract][Full Text] [Related]
53. The role of chemotherapy in patients with stage IB gastric adenocarcinoma: a real-world competing risk analysis.
Xie Y; Du D; Song X; Li X; Ni Z; Huang H
World J Surg Oncol; 2022 Apr; 20(1):123. PubMed ID: 35430809
[TBL] [Abstract][Full Text] [Related]
54. Benefit of Adjuvant Chemoradiotherapy for Gastric Adenocarcinoma: A SEER Population Analysis.
Seyedin S; Wang PC; Zhang Q; Lee P
Gastrointest Cancer Res; 2014 May; 7(3-4):82-90. PubMed ID: 25276261
[TBL] [Abstract][Full Text] [Related]
55. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
[TBL] [Abstract][Full Text] [Related]
56. Comparative effectiveness of primary tumor resection in patients with stage III pancreatic adenocarcinoma.
Sun K; Li W; Han J; Wu H
BMC Cancer; 2019 Aug; 19(1):761. PubMed ID: 31370893
[TBL] [Abstract][Full Text] [Related]
57. Real-world implications of nonbiological factors with staging, clinical management, and prognostic prediction in pancreatic ductal adenocarcinoma.
Wang C; Chen H; Deng X; Xu W; Shen B
Cancer Med; 2023 Jan; 12(1):651-662. PubMed ID: 35661437
[TBL] [Abstract][Full Text] [Related]
58. Additional chemotherapy improves survival in stage II-III pulmonary sarcomatoid carcinoma patients undergoing surgery: a propensity scoring matching analysis.
Cen Y; Yang C; Ren J; Gong Y; Xie C
Ann Transl Med; 2021 Jan; 9(1):24. PubMed ID: 33553317
[TBL] [Abstract][Full Text] [Related]
59. Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients.
Li X; Zhang C; Sun Z; Yang F; Xiao R; Sui X; Jiang G; Zhong W; Wang J
Lung Cancer; 2019 Jul; 133():75-82. PubMed ID: 31200832
[TBL] [Abstract][Full Text] [Related]
60. Studying the impact of marital status on diagnosis and survival prediction in pancreatic ductal carcinoma using machine learning methods.
Chen Q; Hu Y; Lin W; Huang Z; Li J; Lu H; Dai R; You L
Sci Rep; 2024 Mar; 14(1):5273. PubMed ID: 38438400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
